e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Asthma drugs: new findings
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Is sustained control of severe asthma possible? A composite score to assess 1-year of asthma control
A. Bourdin, N. Molinari, L. Halimi, G. Marin, M. Varin, A. S. Gamez, I. Vachier, P. Chanez (Montpellier, Marseille, France)
Source:
Annual Congress 2013 –Asthma drugs: new findings
Session:
Asthma drugs: new findings
Session type:
Thematic Poster Session
Number:
4126
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Bourdin, N. Molinari, L. Halimi, G. Marin, M. Varin, A. S. Gamez, I. Vachier, P. Chanez (Montpellier, Marseille, France). Is sustained control of severe asthma possible? A composite score to assess 1-year of asthma control. Eur Respir J 2013; 42: Suppl. 57, 4126
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Assessing the risk of future severe asthma exacerbations using CARAT questionnaire and lung function
Source: Annual Congress 2013 –Lung function tests to monitor airway diseases
Year: 2013
CompEx – A novel composite asthma exacerbation endpoint
Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD
Year: 2015
Comparison of clinical features of severe persistent asthma and refractory asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Dupilumab reduces severe exacerbations in periostin-high and periostin-low asthma patients
Source: International Congress 2016 – Asthma: from basic mechanisms to novel therapeutic perspectives
Year: 2016
Asthma control, symptoms and exacerbations across treatment levels in patients with asthma
Source: Annual Congress 2013 –Management of respiratory diseases in primary care
Year: 2013
Exacerbations and symptoms remain common in patients with asthma control: A survey of 8000 patients in Europe
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
Respiratory effectiveness group study: Predictors of frequent severe asthma exacerbations
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015
The effect of regional differences on visual arts interpretation in exacerbation and stable periods of chronic airway diseases
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
Predictors of severe asthma exacerbations, poor asthma control and beta-agonist overuse in adult asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Characteristics and medication use of the patients with acute exacerbations of asthma-COPD overlap syndrome
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Prevalence of refractory asthma in population with severe asthma
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
A new observer independent method to assess therapy response in children with severe asthma based on daily lung function
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
Poor adherence to ICS treatment in patients with chronic respiratory diseases
Source: Annual Congress 2013 –Monitoring symptoms and quality of life
Year: 2013
Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment?
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Fatigue and decreased health can predict mortality in COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Physiological and biological predictors of length of stay and recovery in adults with acute asthma
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
A pilot study to assess the efficacy of breathlessness plans for patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Sesonal variations of severe asthma exacerbations in the US
Source: International Congress 2014 – Risk factors for respiratory disease
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept